Compare AdaptHealth Corp (AHCO) vs Howmet Aerospace Inc (HWM) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

Howmet Aerospace (HWM) trades at $277.91, up 2.77% today, reflecting strong momentum in the aerospace and defense sectors. The stock exhibits bullish technical signals with support at $273 and resistance at $282. Recent earnings show mixed results, with Q1 2026 missing estimates, but robust profitability metrics like a 20.22% net margin and 33.98% ROE highlight operational strength. Positive sentiment is driven by defense demand and commercial aerospace growth, as noted in Zacks Investment Research articles from July 2026.

Outlook remains positive with an 83% analyst buy rating and a $313.50 consensus price target, suggesting 13% upside. Risks include premium valuations (P/E of 62.74) and execution challenges amid economic uncertainty. The company's cash flow growth and dividend payments support investor confidence, but high multiples warrant caution for new entries.